Microbial De novo Sequencing

De novo sequencing can sequence the genome of a species without any reference genome information, splice and assemble it by bioinformatics analysis methods, and obtain the genome sequence map of the species, to promote the follow-up research of the species. It offers reference genome assembly for rarely studied species. Using de novo sequencing to obtain the genomic information of microbes provides a fresh start for exploring the genetic structure and functions, studying the evolutionary origin of microbial populations, as well as developing potential applications of these abundant microbes in medicine, disease, agriculture, and the environment.

Category:

Novogene offers de novo sequencing services using both PacBio and Illumina platforms. We provide multifaceted sequencing services including genome survey, draft map, complete map, and fine map tailored to different research needs. For each project, our scientists will design the best sequencing strategy utilizing an optimal combination of short reads and long-range sequencing information to achieve the most comprehensive de novo assembly results for your genome of interest.

Applications

For individual research:

  • Virulence research
  • Drug resistance mechanism
  • Molecular markers
  • Vaccine development

For population research:

  • Evolution relationship
  • Population size
  • Epidemiology
  • Microbial evolution

Benefits

Highly experienced: We have completed numerous microbial De novo sequencing projects with 20 publications in top-tier journals.

Largest sequencing capacity: We have the largest Illumina and PacBio sequencing capacity in the world, allowing us to provide high-quality data, fast turnaround, and affordable prices.

n-depth data mining: We have complete solutions for in-depth analysis of individual variations and interpretation of population evolutionary history to solve your biological problems that interest you.

Accuracy: Creates accurate reference sequences, even for complicated or polyploid genomes.

Specifications: DNA Sample Requirements

Platform Type Sample Type Amount (Qubit®) Purity
Illumina

NovaSeq 6000

Genomic DNA ≥ 200 ng A260/280=1.8-2.0
no degradation,
no contamination
PacBio Sequel IIe
DNA CLR library
HMW Genomic DNA
(Bacteria and Fungus)
≥ 5 μg
(Concentration ≥ 70 ng/μL)
A260/280=1.7-2.0;
A260/230=1.3-2.6;
*NC/QC=0.95-3.00
Fragments should be  ≥ 20 kb
PacBio sequel IIe
DNA HiFi library
HMW Genomic DNA
(Fungus)
≥ 8 μg
(Concentration ≥ 70 ng/μL)
A260/280=1.7-2.0;
A260/230=1.3-2.6;
*NC/QC=1.0-2.2
Fragments should be  ≥ 20 kb
Nanopore PromethION HMW Genomic DNA
(Bacteria and Fungus)
≥ 6 μg
(Concentration ≥ 60 ng/μL)
A260/280=1.7-2.2;
A260/230=1.3-2.6;
*NC/QC=0.95-3.00
Fragments should be ≥ 20 kb

* NC/QC: NanoDrop concentration/Qubit concentration

Specifications: Sequencing & Analysis

Platform Type Illumina NovaSeq PacBio Sequel II/IIe System  
Read Length Paired-end 150 bp N50>15 kb, long read lengths up to 25 kb(CCS)  
Recommended Sequencing Depth ≥ 50x for bacterial and fungal genomes ≥ 100X for bacterial genomes ≥ 50X for fungal genomes  
Data Analysis Bacterial and Fungal Draft Map

Standard Analysis

Data quality control

Genome preliminarily assembly

Genome component analysis: gene structure prediction, repetitive sequences, non-coding RNAs

Gene function annotation

 

Bacteria Complete Map

Standard Analysis

Data quality control

Genome assembly

Genome component analysis

Repeat annotation

Coding gene annotation

ncRNA annotation

Gene function annotation

GO annotation,

KEGG annotation,

COG  annotation

NR annotation,

TCDB annotation

Pfam annotation

Swiss-Prot annotation

Genome cycle graph

 

Fungus Fine Map

Standard Analysis

Data quality control

Genome advanced assembly

Genome survey

Genome component analysis

Repeat annotation

Coding gene annotation

ncRNA annotation

Gene function annotation

GO annotation,

KEGG annotation,

NR annotation,

KOG annotation

Pfam annotation

Swiss-Prot annotation.

Project Workflow

Animal and Plant Whole Genome Sequencing

The first step of the project workflow involves the sample quality control (Sample QC) to ensure that your samples meet the criteria of the Microbial De novo Sequencing. Then, the appropriate library is prepared according to your target organism and application and subsequently tested for its quality (Library QC). Next, the sequenced sample and the resulting data are also checked for their quality (Data QC). Finally, bioinformatic analyses are performed and publication-ready results are provided. The following flowsheet describes the step-by-step protocol our Microbial De novo Sequencing follows.

GeneSmart tự hào là đơn vị tiên phòng đầu tiên tại Việt Nam cung cấp giải pháp:

1. Giải trình tự tế bào đơn (SINGLE-CELL SEQUENCING);

2. Chuẩn bị mẫu tự động (AUTOMATED LIQUID HANDLING);

3. Xét nghiệm và chẩn đoán bệnh nhiễm (DIAGNOSIS OF INFECTIOUS DISEASE);

4. Sinh chiết lỏng (LIQUID BIOPSY)

5. Giải phẫu bệnh sinh học phân tử (MOLECULAR PATHOLOGY)

6. Nghiên cứu ung thư (CANCER RESEARCH)

7. Nghiên cứu miễn dịch (IMMUNOLOGY)

8. Khoa học hình sự (FORENSIC)

9. Trữ mẫu sinh học (Ngân hàng sinh học, BIOBANKING)

-----------------------

CÔNG TY TNHH KHOA HỌC CÔNG NGHỆ GENESMART (MST: 0315672982)

Địa chỉ: 65-67 Đường Số 5 - Cư xá Bình Thới, Phường 8, Quận 11, Thành phố Hồ Chí Minh.

Hotline: +84 947 528 778 | Website: https://genesmart.vn/

Email: [email protected] hoặc [email protected]

Download Flyer

Menu Ẩn